Skip to Main Content
Important Announcement: The New Library System and updated E-resource login process are Here!. As part of
OhioLINK, Ohio's academic library consortium, the NEOMED Library is updating its 30-year-old shared systems. The new system allows researchers to "discover" print and electronic resources with a single search. Click
here to start using the new system.
Additionally, we have also changed the way that you all will login for off-campus access to the electronic resources provided by the NEOMED Library. All NEOMED students, faculty, clinical faculty, staff, and retirees, will click on the "Login using your NEOMED Network credentials" link on the login page. From there, you will be routed through NEOMED's network login process using the same login credentials that you use for logging into your email, Sharepoint, and other essential NEOMED networked resources.
Please be patient with us as we get everything situated for your use and contact us with any questions at 330-325-6600 or e-mail
library@neomed.edu for help.
Diabetes
- Comparing metformin and glyburide in a combination medication as well as monotherapy in the treatment of diabetes mellitus type II
- Comparing exenatide versus insulin glargine in the treatment of diabetes mellitus type II
- Comparing insulin glulisine vs. insulin lispro for treating type II diabetes
- Rosiglitazone vs. pioglitazone for treating type II diabetes
- Rosiglitazone vs. pioglitazone for diabetic patients at risk for coronary heart disease
- Rosiglitazone vs. insulin for diabetic patients at risk for coronary heart disease
- Pioglitazone vs. insulin for diabetic patients at risk for coronary heart disease
- Liraglutide vs. glimepiride to treat type II diabetes
- Metformin vs. Actos for treating diabetes
- Comparing liraglutide to exenatide for treating type II diabetes
- Diet and exercise versus pioglitazone for treating obesity
- Insulin glulisine vs. insulin lispro for treating diabetes
- Comparing metformin to sulfonylureas: cardiovascular and all-cause mortality
- Metformin and glimepiride vs. metformin and empagliflozin for treating type 2 diabetes
- Exenatide vs. glimepiride for treating type 2 diabetes
- Vildagliptin versus metformin for treating type 2 diabetes
Osteoporosis
- Alendronate vs. risedronate for treating osteoporosis
- Teriparatide and denosumab versus teriparatide alone for treating osteoporosis
- Teriparatide and denosumab versus denosumab alone for treating osteoporosis
- Ibandronate versus risedronate for treating osteoporosis
- Romosozumab versus alendronate for preventing fractures in women with osteoporosis
- Ibandronate versus alendronate for treating osteoporosis
